Medical Research
(H05)
990 on File
INTERNATIONAL CANNABINOID RESEARCH SOCIETY
Financial strength (30%)
99/100
Reliability (20%)
50/100
Effectiveness (25%)
78/100
Impact (25%)
No data yet
Register and add impact metrics to be rated above three stars
CharityAI™ Score
Not yet evaluated
Financial Overview — FY 2025
$225K
Total Revenue
$242K
Total Expenses
$629K
Net Assets
0
Employees
Revenue Sources
Expense Breakdown
Program Expense Ratio
84.1%
Fundraising Efficiency
N/A
Operating Reserve
31.20x
Liability-to-Asset
0.2%
Revenue Diversification
59.0%
Compared with Peers
FY 2025
Compared with 300 similar organizations
(United States, Medical Research, $100K–$1M in expenses), FY 2025.
This organization
Middle half of peers (P25–P75)
Peer median
| Ratio | This org | Peer median | Position (P10 → P90) | |
|---|---|---|---|---|
|
Program expense ratio
Program expenses / total expenses
· higher is better
|
84.1% | 84.6% |
P10P90
|
Below median |
|
Admin expense ratio
Management and general / total expenses
· lower is better
|
15.9% | 10.0% |
P10P90
|
Below median |
|
Fundraising expense ratio
Fundraising expenses / total expenses
· lower is better
|
0.0% | 0.0% |
P10P90
|
Top quarter |
|
Operating reserve
Months of expenses covered by net assets
· higher is better
|
31.2 mo | 11.7 mo |
P10P90
|
Above median |
|
Liabilities to assets
Total liabilities / total assets
· lower is better
|
0.2% | 0.0% |
P10P90
|
Below median |
|
Revenue concentration
Share of revenue from the largest source
· lower is better
|
59.0% | 92.2% |
P10P90
|
Top quarter |
|
Surplus margin
Surplus as a share of revenue
|
-7.6% | -1.6% |
P10P90
|
Financial History
| Year | Revenue | Expenses | Net Assets | Program % | Staff |
|---|---|---|---|---|---|
| 2025 | $225K | $242K | $629K | 84.1% | 0 |
| 2023 | $433K | $433K | $615K | 90.4% | 0 |
| 2022 | $393K | $365K | $615K | 88.7% | 0 |
| 2021 | $294K | $202K | N/A | — | 0 |
Donor Reviews
Write a ReviewNo reviews yet
Be the first to share your experience with this organization.